Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Marcelo F. Di Carli, M.D.

Co-Author

This page shows the publications co-authored by Marcelo Di Carli and Viviany Taqueti.
Connection Strength

11.367
  1. Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options: JACC State-of-the-Art Review. J Am Coll Cardiol. 2018 11 27; 72(21):2625-2641.
    View in: PubMed
    Score: 0.840
  2. Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction. Eur Heart J. 2018 03 07; 39(10):840-849.
    View in: PubMed
    Score: 0.799
  3. Response by Taqueti and Di Carli to Letter Regarding Article, "Excess Cardiovascular Risk in Women Relative to Men Referred for Coronary Angiography Is Associated With Severely Impaired Coronary Flow Reserve, Not Obstructive Disease". Circulation. 2017 07 11; 136(2):241-242.
    View in: PubMed
    Score: 0.764
  4. Excess Cardiovascular Risk in Women Relative to Men Referred for Coronary Angiography Is Associated With Severely Impaired Coronary Flow Reserve, Not Obstructive Disease. Circulation. 2017 02 07; 135(6):566-577.
    View in: PubMed
    Score: 0.730
  5. Clinical significance of noninvasive coronary flow reserve assessment in patients with ischemic heart disease. Curr Opin Cardiol. 2016 11; 31(6):662-669.
    View in: PubMed
    Score: 0.728
  6. Radionuclide myocardial perfusion imaging for the evaluation of patients with known or suspected coronary artery disease in the era of multimodality cardiovascular imaging. Prog Cardiovasc Dis. 2015 May-Jun; 57(6):644-53.
    View in: PubMed
    Score: 0.650
  7. Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease. Circulation. 2015 Feb 10; 131(6):528-35.
    View in: PubMed
    Score: 0.638
  8. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. Circulation. 2015 Jan 06; 131(1):19-27.
    View in: PubMed
    Score: 0.636
  9. Translational molecular imaging: repurposing an old technique to track cell migration into human atheroma. J Am Coll Cardiol. 2014 Sep 09; 64(10):1030-2.
    View in: PubMed
    Score: 0.627
  10. Impaired Coronary Vasodilator Reserve and Adverse Prognosis in Patients With Systemic Inflammatory Disorders. JACC Cardiovasc Imaging. 2021 Mar 10.
    View in: PubMed
    Score: 0.246
  11. Cardiopulmonary transit time: A novel PET imaging biomarker of in vivo physiology for risk stratification of heart transplant recipients. J Nucl Cardiol. 2021 Jan 04.
    View in: PubMed
    Score: 0.243
  12. Absolute Quantitation of Cardiac 99mTc-Pyrophosphate Using Cadmium-Zinc-Telluride-Based SPECT/CT. J Nucl Med. 2021 May 10; 62(5):716-722.
    View in: PubMed
    Score: 0.238
  13. Coronary vasomotor dysfunction in cancer survivors treated with thoracic irradiation. J Nucl Cardiol. 2020 Jul 20.
    View in: PubMed
    Score: 0.235
  14. Hypertensive coronary microvascular dysfunction: a subclinical marker of end organ damage and heart failure. Eur Heart J. 2020 07 01; 41(25):2366-2375.
    View in: PubMed
    Score: 0.235
  15. Coronary microvascular dysfunction in patients with psoriasis. J Nucl Cardiol. 2020 May 17.
    View in: PubMed
    Score: 0.233
  16. Coronary Microvascular Dysfunction, Left Ventricular Remodeling, and Clinical Outcomes in Patients With Chronic Kidney Impairment. Circulation. 2020 01 07; 141(1):21-33.
    View in: PubMed
    Score: 0.225
  17. Diagnostic Accuracy of Advanced Imaging in Cardiac Sarcoidosis. Circ Cardiovasc Imaging. 2019 06; 12(6):e008975.
    View in: PubMed
    Score: 0.218
  18. Coronary microvascular dysfunction, left ventricular remodeling, and clinical outcomes in aortic stenosis. J Nucl Cardiol. 2021 Apr; 28(2):579-588.
    View in: PubMed
    Score: 0.216
  19. Coronary Microvascular Dysfunction and Cardiovascular Risk in Obese Patients. J Am Coll Cardiol. 2018 08 14; 72(7):707-717.
    View in: PubMed
    Score: 0.206
  20. Myocardial Scar But Not Ischemia Is Associated With Defibrillator Shocks and Sudden Cardiac Death in Stable Patients With Reduced Left Ventricular Ejection Fraction. JACC Clin Electrophysiol. 2018 09; 4(9):1200-1210.
    View in: PubMed
    Score: 0.205
  21. Diagnostic and prognostic value of myocardial blood flow quantification as non-invasive indicator of cardiac allograft vasculopathy. Eur Heart J. 2018 01 21; 39(4):316-323.
    View in: PubMed
    Score: 0.198
  22. Coronary Microvascular Dysfunction Identifies Patients at High Risk of Adverse Events Across Cardiometabolic Diseases. J Am Coll Cardiol. 2017 12 05; 70(22):2835-2837.
    View in: PubMed
    Score: 0.196
  23. Coronary flow reserve is predictive of the risk of cardiovascular death regardless of chronic kidney disease stage. Kidney Int. 2018 02; 93(2):501-509.
    View in: PubMed
    Score: 0.194
  24. Integrated Noninvasive Physiological Assessment of Coronary Circulatory Function and Impact on Cardiovascular Mortality in Patients With Stable Coronary Artery Disease. Circulation. 2017 Dec 12; 136(24):2325-2336.
    View in: PubMed
    Score: 0.193
  25. Ranolazine in Symptomatic Diabetic Patients Without Obstructive Coronary Artery Disease: Impact on Microvascular and Diastolic Function. J Am Heart Assoc. 2017 May 04; 6(5).
    View in: PubMed
    Score: 0.188
  26. Invasive FFR and Noninvasive CFR in the Evaluation of Ischemia: What Is the Future? J Am Coll Cardiol. 2016 06 14; 67(23):2772-2788.
    View in: PubMed
    Score: 0.177
  27. Prognostic Value of Coronary Flow Reserve in Patients with Dialysis-Dependent ESRD. J Am Soc Nephrol. 2016 06; 27(6):1823-9.
    View in: PubMed
    Score: 0.169
  28. Response to letter regarding article, "effects of sex on coronary microvascular dysfunction and cardiac outcomes". Circulation. 2015 Mar 17; 131(11):e376.
    View in: PubMed
    Score: 0.163
  29. Increased microvascularization and vessel permeability associate with active inflammation in human atheromata. Circ Cardiovasc Imaging. 2014 Nov; 7(6):920-9.
    View in: PubMed
    Score: 0.157
  30. Effects of sex on coronary microvascular dysfunction and cardiac outcomes. Circulation. 2014 Jun 17; 129(24):2518-27.
    View in: PubMed
    Score: 0.153
  31. Preserved coronary flow reserve effectively excludes high-risk coronary artery disease on angiography. J Nucl Med. 2014 Feb; 55(2):248-55.
    View in: PubMed
    Score: 0.150
  32. Women who experience a myocardial infarction at a young age have worse outcomes compared with men: the Mass General Brigham YOUNG-MI registry. Eur Heart J. 2020 11 07; 41(42):4127-4137.
    View in: PubMed
    Score: 0.060
  33. Inter-observer reproducibility and intra-observer repeatability in 99mTc-pyrophosphate scan interpretation for diagnosis of transthyretin cardiac amyloidosis. J Nucl Cardiol. 2020 Sep 11.
    View in: PubMed
    Score: 0.059
  34. Appropriateness of inpatient stress testing: Implications for development of clinical decision support mechanisms and future criteria. J Nucl Cardiol. 2019 Nov 18.
    View in: PubMed
    Score: 0.056
  35. Association between Nonalcoholic Fatty Liver Disease at CT and Coronary Microvascular Dysfunction at Myocardial Perfusion PET/CT. Radiology. 2019 05; 291(2):330-337.
    View in: PubMed
    Score: 0.054
  36. Erratum to: Isolated cardiac sarcoidosis: A focused review of an under-recognized entity. J Nucl Cardiol. 2018 Aug; 25(4):1147.
    View in: PubMed
    Score: 0.051
  37. Evolving, innovating, and revolutionary changes in cardiovascular imaging: We've only just begun! J Nucl Cardiol. 2018 06; 25(3):758-768.
    View in: PubMed
    Score: 0.050
  38. Complementary Value of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Assessment of Cardiac Sarcoidosis. Circ Cardiovasc Imaging. 2018 01; 11(1):e007030.
    View in: PubMed
    Score: 0.049
  39. Defining Quality in Cardiovascular Imaging: A Scientific Statement From the American Heart Association. Circ Cardiovasc Imaging. 2017 Dec; 10(12).
    View in: PubMed
    Score: 0.049
  40. Isolated cardiac sarcoidosis: A focused review of an under-recognized entity. J Nucl Cardiol. 2018 08; 25(4):1136-1146.
    View in: PubMed
    Score: 0.045
  41. Increased arterial inflammation in individuals with stage 3 chronic kidney disease. Eur J Nucl Med Mol Imaging. 2016 Feb; 43(2):333-339.
    View in: PubMed
    Score: 0.042
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.